One of every 10 clinical trials for adults with cancer ends prematurely because researchers can’t get enough people to test new treatments, scientists report.
Too few cancer patients enroll in studies, analysis finds
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You